Phyllis Whiteley - Profile and Investment Details

Investor Profile

Phyllis Whiteley is a Venture Capital, Angel/Individual, Investor based in United States with a diverse investment portfolio that includes companies such as Springboard Enterprises, Biota, University of Michigan, School of Nursing, Balance Therapeutics, Lassogen, Inc., RainDance Technologies - Acquired by BioRad, UCSF Leadership Council For Global Health, 1910 Genetics, Bodyport, NVision, Alydia Health, Sequenta, Inc. - Acquired by Adaptive Biotechnologies, Carrum Health, University of Texas System, OneSpot, Analyte Health, Artificial, Inc., Self-employed, . Over time, Phyllis Whiteley has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Phyllis Whiteley is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Mobility, Wellness, Healthcare Innovation, Engineering, Manufacturing, Biotechnology, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Weight Management, Precision Medicine, Cannabinoids, Food and Beverage, Disruptive technology, Research, Consulting, CPG Technology, Personalized Medicine, Digital Health, Medical, Information Technology, B2B, Therapeutics, Health Tech, Machine Learning, Pharmaceuticals may find it worthwhile to explore potential connections with Phyllis Whiteley, as their portfolio suggests a familiarity and interest in this area.

Understanding Phyllis Whiteley’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.